A new treatment for advanced urothelial cancer was effective with tolerable side effects in an international, multi-center phase 2 clinical trial. The trial results prompted a U.S. Food and Drug Administration (FDA) accelerated approval of the treatment on April 13, giving patients with this very aggressive type of cancer a new therapeutic option.
source https://www.sciencedaily.com/releases/2021/08/210802160627.htm
Tuesday, 3 August 2021
Related Posts
Hubble finds evidence of water vapor at Jupiter's moon GanymedeAstronomers have uncovered evidence of water vapor in the atmosphere o… Read More
Scientists model 'true prevalence' of COVID-19 throughout pandemicScientists have developed a statistical framework that incorporates ke… Read More
Brain's 'memory center' needed to recognize image sequences but not single sightsThe visual cortex stores and remembers individual images, but when the… Read More
Second COVID-19 mRNA vaccine dose found safe following allergic reactions to first doseA new study reports that among individuals who had an allergic reactio… Read More
Supernova's 'fizzled' gamma-ray burstOn Aug. 26, 2020, NASA's Fermi Gamma-ray Space Telescope detected a pu… Read More
What happens to marine life when oxygen is scarce?In September of 2017, marine biologists were conducting an experiment … Read More
0 comments: